Skip to main content

Background Image

Working together to make a positive impact on healthcare and on lives.

Why Work With Us?

Purdue Pharma (Canada) is a leader in the development, manufacturing and commercialization of medicines for pain management and central nervous system disorders, and we are one of the limited number of pharmaceutical companies in the country that continues to maintain a fully integrated research and development formulation laboratory, drug development function and manufacturing capability in Canada. We also employ a fully operational sales team focused on both primary and speciality care physicians, as well as hospital care across the country. Purdue Pharma (Canada) is expanding our capabilities to include new therapeutic areas that support Canadian patients. Privately held and founded by physicians, Purdue Pharma (Canada) is independently associated with the worldwide Purdue/Napp/Mundipharma network of companies.

Our Areas of Interest

Purdue Pharma (Canada) is committed to building successful partnerships centred on innovative products and technologies with organizations around the world who can help achieve our mission and broaden the reach of these products to Canadian patients. We work with companies who are interested in licensing agreements and have products at various stages in their lifecycle – as early as candidates in phase three clinical trials to products approved by Health Canada, products already launched in the Canadian market, or products launched in another country that would benefit Canadian patients. Our broad portfolio of prescription and non-prescription medications helps patients suffering from chronic pain, ADHD, chemotherapy-induced nausea and vomiting, and various ophthalmic conditions. Purdue Pharma (Canada) welcomes partnerships that leverage our strengths in these core therapeutic areas.

Our Partners

Purdue Pharma (Canada) is proud to collaborate with the following companies to help bring innovative medicines and technologies to Canada:

For further information pertaining to our business development interests and approaches, please contact:

Cameron Carvalho
Executive Director, Business Development
Purdue Pharma (Canada)
575 Granite Court
Pickering, Ontario
Canada L1W 3W8
T: 905-421-3335
cameron.carvalho@purdue.ca

Let’s meet! We will be in San Francisco during the JP Morgan Healthcare Conference in January 2018. To set up a meeting, please email Cameron Carvalho at cameron.carvalho@purdue.ca

Recent Announcements

Klaria signs exclusive development, license and supply agreement with Purdue Pharma (Canada) for acute treatment of opioid overdose (KL-00514)

Published on August 9, 2017

Uppsala, Sweden and Pickering, Canada, August 9, 2017/CNW/ – Klaria AB (Klaria) (Parent Company, Klaria…

Read More

BIODELIVERY SCIENCES SIGNS EXCLUSIVE AGREEMENT WITH PURDUE PHARMA (CANADA) FOR THE LICENSING AND DISTRIBUTION RIGHTS OF BELBUCA® IN CANADA

Published on July 12, 2017

Raleigh, North Carolina (USA) and Pickering, Ontario (CANADA), July 12, 2017/CNW/: Today, BioDelivery Sciences International…

Read More

Helsinn Group signs Exclusive Agreement with Purdue Pharma (Canada) for the Distribution and Licensing Rights of Aloxi® (palonosetron hydrochloride) in Canada

Published on June 6, 2017

Lugano, Switzerland and Pickering, Canada, June 6, 2017 – Helsinn Group and Purdue Pharma (Canada)…

Read More
↓